This disclosure covers the calendar year 2021 sets out how SV Health Managers LLP (“SV”) undertakes stewardship and shareholder engagement for its public equities fund – International Biotechnology Trust plc (“IBT”).
It is SV’s view that voting at companies, in which SV invests on behalf of IBT, is an important element that encourages the improvement of stewardship which is in the interest of all stakeholders. Voting is a very important pillar of SV’s engagement policy and is a central aspect of an active asset owner.
The principles of how SV’s voting is implemented is described in SV’s engagement policy.
SV uses a third-party vendor, Institutional Shareholder Services (ISS), to implement its voting policy, with the option to the recommended action when it differs from SV’s consideration of the standards for good corporate governance and management of environmental and social issues.
In order to provide full transparency on our voting please find SV’s votes from the period 1 January 2021 to 31 December 2021 - SV IBT Voting 2021
